The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

Although pneumococcal polysaccharide vaccine is a standard preventive intervention — and serves as a "quality indicator" in some settings — controversy over its effectiveness simmers in the ...

and one pneumococcal polysaccharide vaccine (PPSV23) for protection against pneumococcal disease. A serotype is a variation of a bacterium or virus. The immune system may react differently to ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended four novel medicines for approval at its ...

The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for ...

Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...

If you receive PCV15, it should be followed by a dose of pneumococcal polysaccharide vaccine (PPSV23). Part B is medical insurance. It covers preventive healthcare services such as doctor visits ...

Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...

In India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies ...

Vaccination with CAPVAXIVE may not protect all vaccine recipients.

Pregnant patients in their third trimester and postpartum women showed higher risk for IPD compared with nonpregnant patients.